atrial

Sanofi Heart Drug Linked to Liver Damage; Shares Slip 1% as FDA Issues Warning

The SAN drug Multaq, used by patients with atrial flutter and atrial fibrillation, or irregular heart rhythms to prevent strokes, has been reported to have caused liver damage in at least two female patients who were approximately

Multaq was approved in July 2009 by the FDA, and half a million prescriptions have been written for the drug ever since.

Sanofi offices in Bridgewater, N.J.

fda, warning, sanofi aventis, san, heart, drug, doctors, patients, liver damage, multaq, atrial, flutter, fibrillation, irregular, heartbeat, strokes, company, shares

The U.S. Food and Drug Administration has recently released a warning to doctors and patients that Sanofi-Aventis' (SAN) heart drug has been linked to liver damage in several patients.

By Stephanie Shyu
sshyu@fnno.com

Latest News from FNNO

Arbitron Earnings In Retrospect: Up 0.0%...

18 days ago, on May 7th, 2013, Arbitron (NYSE:ARB) reported its earnings. Analysts, on ...

Chiquita Brands International Earnings I...

Two weeks ago on May 7th, 2013 Chiquita Brands International (NYSE:CQB) reported earnin ...

The Williams Cos Earnings Review: 18 Day...

When The Williams Cos (NYSE:WMB) reported earnings 18 days ago on May 7th, 2013, analys ...

Granite Construction Earnings Review: 16...

When Granite Construction (NYSE:GVA) reported earnings 16 days ago on May 9th, 2013, an ...

Earnings Flashback: Since Reporting Quar...

Two weeks ago on May 7th, 2013 DaVita (NYSE:DVA) reported earnings and analysts, on ave ...

Earnings Look Back: ProAssurance Is Up 2...

19 days ago, on May 6th, 2013, ProAssurance (NYSE:PRA) reported its earnings. Analysts ...

Post Earnings Update: Apache Has Climbed...

Two weeks ago on May 9th, 2013 Apache (NYSE:APA) reported earnings and analysts, on ave ...

Global Cash Access Holdings Earnings In ...

When Global Cash Access Holdings (NYSE:GCA) reported earnings two weeks ago on May 7th, ...

Most Popular Video News